We provide patients throughout the Netherlands with access to generic medicines that contain the same active substances as equivalent brand-name medicines. Moreover, they must comply with the same strict regulatory requirements. The only difference is the price: generics are much cheaper. We have a wide range of generic medicines that help to keep healthcare accessible and affordable.

In addition to our generic medicines, we also supply medical devices:

• Relegs®, a special device for RLS (restless legs syndrome)
• We are the Netherlands’ distributor of the AeroChamber^® Plus Flow-Vu^®, AeroTrach Plus^® en AeroChamber2go™ inhaler devices for respiratory medicines

An inventor of a new medicine — known as the ‘brand-name medicine’ — retains the exclusive right to produce and market that medicine for a specified period of time. Once that right expires, other companies may also produce and market the medicine, known as a ‘generic medicine’. This medicine contains the same active substances as the brand-name medicine.

As generic medicines can be produced at a lower cost, they help to keep healthcare affordable. Before a company is allowed to sell a generic medicine, however, it requires government approval that the ingredients are just as safe and effective as those in the brand-name medicine.

More about generic medicine

Yes. All of our products undergo thorough testing and comply with the strict regulatory requirements for medicines and medical devices.

Our products comply with the strictest quality requirements for medicines and medical devices. These requirements are underpinned by strict guidelines set by regulators such as the Dutch Medicines Evaluation Board (CBG-MEB). We follow these guidelines to the letter. A medicine must have received marketing authorisation from the CBG before being sold in the Netherlands.

Our development process has several stages:

• Extensive research
• Preclinical studies
• Clinical testing
• Regulatory approval and authorisation

We are fully committed to ensuring product safety and efficacy at all times.

As generic medicines can be produced at a fraction of the cost of brand-name medicines, they play a vital role in keeping healthcare affordable and accessible for the nation.

Quality assurance (QA) relates to the manufacture, transport and storage of medicines. It aims to prevent issues linked to quality by ensuring total compliance with quality standards and requirements set by the regulator. Quality control (QC), on the other hand, focuses on medicines after manufacture and aims to detect any concerns linked to quality.

Focus Care believes that sustainability and caring for the environment are key features of corporate social responsibility (CSR). We have established initiatives to reduce waste, improve energy efficiency and prioritise ethical procurement.

Your standard health insurance will cover the costs of most of the Focus Care medicines prescribed by your GP or specialist.

• In some cases, you may need to pay a personal contribution.
• The amount remaining after deducting your personal contribution is part of your mandatory insurance excess.
• The amount remaining after that is part of your voluntary insurance excess (if you have any).
• Your health insurer will reimburse the remaining amount.

Please visit www.medicijnkosten.nl to see which medicines in the Netherlands are covered by standard health insurance and, if not, what alternatives are available. Insurance policies differ. To find out what you are covered for, please visit your insurer’s website.

We do not currently sell products on our website.

No, you cannot use these medicines. You should not take the medicines after the expiry date stated on the packaging.

Please note that medicines must be stored properly to maintain their effectiveness. The package leaflet will tell you how to store the medicine.

1. To report a side effect, please call +31 (0)85-792 08 00 or send an e-mail to pv@focuscare.nl.
2. If you have a question about one of our products, please call +31 (0)85-792 08 00 or send an e-mail to pv@focuscare.nl.
3. If you have a different question, please call +31 (0)85-792 08 00 or send an e-mail to info@focuscare.nl.
4. If you wish to submit a complaint about one of our products, please call +31 (0)85-792 08 00 or send an e-mail to complaints@focuscare.nl.

Medicines can cause side effects. Although many side effects are identified in clinical trials, rare side effects may sometimes come to light only after the medicine has been used on a larger scale.

It is therefore crucial that you report any suspected side effects, even if you are unsure of their cause. These reports allow us to better understand the nature and frequency of side effects and take action if necessary.

Your report helps to guarantee the safety of our medicines and protect patients’ health.

You can report side effects by:

• e-mailing pv@focus-care.nl
• calling +31 (0)85 – 792 08 00 or
• completing the form below

This information will be used solely to register the side effects. Your privacy will be guaranteed at all times.

We process personal data according to the European Good Manufacturing Practice (GMP) guidelines, Good Pharmacovigilance Practice (GVP), the Dutch Foundation for the Code for Pharmaceutical Advertisings (CGR) Code of Conduct for Pharmaceutical Advertising and the EU General Data Protection Regulation (GDPR).